2型糖尿病患者-话题@MedSci

#2型糖尿病患者#

722篇内容 | 7128人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1383410, encodeId=f63f13834107c, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性, objectType=article, longId=130540, objectId=df9e130540b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df9e130540b9, replyNumber=0, likeNumber=80, createdTime=2018-02-26, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df9e130540b9, moduleTitle=Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df9e130540b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383409, encodeId=d78d1383409a0, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Kidney int：2型糖尿病患者血液透析后的钠含量如何？, objectType=article, longId=130258, objectId=89b31302586b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89b31302586b, replyNumber=0, likeNumber=49, createdTime=2018-02-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89b31302586b, moduleTitle=Kidney int：2型糖尿病患者血液透析后的钠含量如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89b31302586b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383408, encodeId=8b851383408f4, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Metabolism：Canagliflozin与格列美脲对2型糖尿病患者脂肪细胞因子和炎症标志物的影响！, objectType=article, longId=130209, objectId=713313020972, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=713313020972, replyNumber=0, likeNumber=25, createdTime=2018-02-22, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=713313020972, moduleTitle=Metabolism：Canagliflozin与格列美脲对2型糖尿病患者脂肪细胞因子和炎症标志物的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=713313020972)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383407, encodeId=1959138340e52, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Metabolism：2型糖尿病患者糖尿病相关住院和住院死亡预测模型的建立和验证！, objectType=article, longId=130208, objectId=95221302085b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=95221302085b, replyNumber=0, likeNumber=101, createdTime=2018-02-21, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=95221302085b, moduleTitle=Metabolism：2型糖尿病患者糖尿病相关住院和住院死亡预测模型的建立和验证！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=95221302085b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383406, encodeId=44cc1383406db, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：强化血压控制对2型糖尿病患者的影响！, objectType=article, longId=129561, objectId=2fc512956170, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fc512956170, replyNumber=0, likeNumber=73, createdTime=2018-02-12, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fc512956170, moduleTitle=Diabetes Obes Metab：强化血压控制对2型糖尿病患者的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fc512956170)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383405, encodeId=ffc41383405cd, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Kidney int：2型糖尿病患者早期进行性肾衰竭标志物的新研究!, objectType=article, longId=129512, objectId=7caa12951239, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7caa12951239, replyNumber=0, likeNumber=57, createdTime=2018-02-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7caa12951239, moduleTitle=Kidney int：2型糖尿病患者早期进行性肾衰竭标志物的新研究!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7caa12951239)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383404, encodeId=1a6c1383404e5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：2型糖尿病患者ACS或AIS后使用利格列汀安全吗？, objectType=article, longId=129449, objectId=0b3512944904, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b3512944904, replyNumber=0, likeNumber=48, createdTime=2018-02-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b3512944904, moduleTitle=Cardiovasc Diabetol：2型糖尿病患者ACS或AIS后使用利格列汀安全吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b3512944904)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383403, encodeId=367013834031a, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=J Diabetes Complications：2型糖尿病患者中，高丙氨酸氨基转移酶水平患者的临床表型与高风险的NAFLD纤维化评分患者的临床表型不同, objectType=article, longId=129239, objectId=0cdf129239ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cdf129239ee, replyNumber=0, likeNumber=53, createdTime=2018-02-09, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cdf129239ee, moduleTitle=J Diabetes Complications：2型糖尿病患者中，高丙氨酸氨基转移酶水平患者的临床表型与高风险的NAFLD纤维化评分患者的临床表型不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cdf129239ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383402, encodeId=47291383402a9, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetic Med：HypoAware心理-教育混合干预与1型和胰岛素治疗的2型糖尿病患者的常规护理相比的成本效益如何？, objectType=article, longId=128531, objectId=791712853181, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=791712853181, replyNumber=0, likeNumber=72, createdTime=2018-02-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=791712853181, moduleTitle=Diabetic Med：HypoAware心理-教育混合干预与1型和胰岛素治疗的2型糖尿病患者的常规护理相比的成本效益如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=791712853181)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383401, encodeId=86cf13834014b, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetic Med：2型糖尿病患者血糖变异的特点？, objectType=article, longId=128529, objectId=361512852920, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=361512852920, replyNumber=0, likeNumber=61, createdTime=2018-02-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=361512852920, moduleTitle=Diabetic Med：2型糖尿病患者血糖变异的特点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=361512852920)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383400, encodeId=092c138340067, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetic Med：德国初级保健机构2型糖尿病患者HbA 1c检测频率较低, objectType=article, longId=128527, objectId=b9b612852e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9b612852e8e, replyNumber=0, likeNumber=78, createdTime=2018-02-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9b612852e8e, moduleTitle=Diabetic Med：德国初级保健机构2型糖尿病患者HbA 1c检测频率较低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b9b612852e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383399, encodeId=6e6a13833994e, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=J Hypertens：2型糖尿病患者家庭早晨SBP目标值应低于125mmHg!, objectType=article, longId=128090, objectId=359612809007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=359612809007, replyNumber=0, likeNumber=58, createdTime=2018-01-30, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=359612809007, moduleTitle=J Hypertens：2型糖尿病患者家庭早晨SBP目标值应低于125mmHg!, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=359612809007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383398, encodeId=49ca13833983f, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者降糖药物相关的糖尿病视网膜病变事件比较！, objectType=article, longId=127918, objectId=d1ad12e91858, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1ad12e91858, replyNumber=0, likeNumber=68, createdTime=2018-01-28, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1ad12e91858, moduleTitle=Diabetes Obes Metab：2型糖尿病患者降糖药物相关的糖尿病视网膜病变事件比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1ad12e91858)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383397, encodeId=8f16138339ec2, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JAHA：2型糖尿病患者主动脉瘤和主动脉夹层的长期风险降低！, objectType=article, longId=127763, objectId=a0ae12e763ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a0ae12e763ff, replyNumber=0, likeNumber=63, createdTime=2018-01-27, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a0ae12e763ff, moduleTitle=JAHA：2型糖尿病患者主动脉瘤和主动脉夹层的长期风险降低！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0ae12e763ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383396, encodeId=22d21383396ec, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：警告！许多2型糖尿病患者存在过度治疗，这样做更危险, objectType=article, longId=127647, objectId=a65412e6473d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a65412e6473d, replyNumber=0, likeNumber=52, createdTime=2018-01-26, rootId=0, userName=智者为医08, userId=4dfa37, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a65412e6473d, moduleTitle=Diabetes Obes Metab：警告！许多2型糖尿病患者存在过度治疗，这样做更危险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a65412e6473d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383395, encodeId=085013833957b, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！, objectType=article, longId=127162, objectId=547a12e162f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=547a12e162f7, replyNumber=0, likeNumber=78, createdTime=2018-01-23, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=547a12e162f7, moduleTitle=JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=547a12e162f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383394, encodeId=d06213833945b, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Am J Epidemiol：中国慢病前瞻性研究，2型糖尿病患者肝癌、胰腺癌和乳腺癌罹患风险高, objectType=article, longId=126824, objectId=0c06126824cf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c06126824cf, replyNumber=0, likeNumber=49, createdTime=2018-01-19, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c06126824cf, moduleTitle=Am J Epidemiol：中国慢病前瞻性研究，2型糖尿病患者肝癌、胰腺癌和乳腺癌罹患风险高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0c06126824cf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383393, encodeId=b16c13833939a, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=SCI REP：无缺血性心脏病的2型糖尿病患者左心室质量指数增加！, objectType=article, longId=126805, objectId=0e6812680545, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e6812680545, replyNumber=0, likeNumber=57, createdTime=2018-01-19, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e6812680545, moduleTitle=SCI REP：无缺血性心脏病的2型糖尿病患者左心室质量指数增加！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e6812680545)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383392, encodeId=2de113833928c, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JCEM：依帕列净可以改善2型糖尿病患者的β细胞的功能？, objectType=article, longId=126507, objectId=5f3412650ef7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f3412650ef7, replyNumber=0, likeNumber=68, createdTime=2018-01-16, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f3412650ef7, moduleTitle=JCEM：依帕列净可以改善2型糖尿病患者的β细胞的功能？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f3412650ef7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383391, encodeId=2c471383391fc, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Care：2型糖尿病患者严重低血糖事件与心血管结局风险之间的相关性分析！, objectType=article, longId=126037, objectId=8b9a12603e20, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b9a12603e20, replyNumber=0, likeNumber=59, createdTime=2018-01-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b9a12603e20, moduleTitle=Diabetes Care：2型糖尿病患者严重低血糖事件与心血管结局风险之间的相关性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b9a12603e20)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2型糖尿病患者

2020-05-29

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Lancet diabetes endo：度拉糖肽作为SGLT2抑制剂的补充治疗，用于血糖控制效果欠佳的2型糖尿病患者的效果和安全性

2018-02-26

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Kidney int：2型糖尿病患者血液透析后的钠含量如何？

2018-02-23

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Metabolism：Canagliflozin与格列美脲对2型糖尿病患者脂肪细胞因子和炎症标志物的影响！

2018-02-22

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Metabolism：2型糖尿病患者糖尿病相关住院和住院死亡预测模型的建立和验证！

2018-02-21

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：强化血压控制对2型糖尿病患者的影响！

2018-02-12

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Kidney int：2型糖尿病患者早期进行性肾衰竭标志物的新研究!

2018-02-11

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：2型糖尿病患者ACS或AIS后使用利格列汀安全吗？

2018-02-11

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

J Diabetes Complications：2型糖尿病患者中，高丙氨酸氨基转移酶水平患者的临床表型与高风险的NAFLD纤维化评分患者的临床表型不同

2018-02-09

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetic Med：HypoAware心理-教育混合干预与1型和胰岛素治疗的2型糖尿病患者的常规护理相比的成本效益如何？

2018-02-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetic Med：2型糖尿病患者血糖变异的特点？

2018-02-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetic Med：德国初级保健机构2型糖尿病患者HbA 1c检测频率较低

2018-02-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

J Hypertens：2型糖尿病患者家庭早晨SBP目标值应低于125mmHg!

2018-01-30

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：2型糖尿病患者降糖药物相关的糖尿病视网膜病变事件比较！

2018-01-28

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JAHA：2型糖尿病患者主动脉瘤和主动脉夹层的长期风险降低！

2018-01-27

智者为医08 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：警告！许多2型糖尿病患者存在过度治疗，这样做更危险

2018-01-26

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JAHA：2型糖尿病患者SGLT2抑制剂的心血管安全和长期非心血管疗效分析！

2018-01-23

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Am J Epidemiol：中国慢病前瞻性研究，2型糖尿病患者肝癌、胰腺癌和乳腺癌罹患风险高

2018-01-19

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

SCI REP：无缺血性心脏病的2型糖尿病患者左心室质量指数增加！

2018-01-19

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JCEM：依帕列净可以改善2型糖尿病患者的β细胞的功能？

2018-01-16

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Care：2型糖尿病患者严重低血糖事件与心血管结局风险之间的相关性分析！

2018-01-11

科室
- - 订阅+
  - 更多科室
工具
服务